Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-052709)

Filing Details

Accession Number:: 0001209191-10-052709
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-02 18:58:32
Reporting Period:: 2010-11-01

Filing Date:: 2010-11-02
Accepted Time:: 2010-11-02 18:58:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949858	Oncogenex Pharmaceuticals Inc.	OGXI	In Vitro & In Vivo Diagnostic Substances (2835)	954343413

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1442675	Daniel Scott Cormack	400-1001 W. Broadway Vancouver A1 V6H 4B1	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-01	10,000	$3.89	18,067	No	4	M	Direct
Common Stock	Disposition	2010-11-01	5,000	$15.45	13,067	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2010-11-01	10,000	$0.00	10,000	$3.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,709	2006-12-16	2010-12-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,092	Indirect	Spouse
Common Stock	25,680	Indirect	By Trycor Investment Trust No. 1

Footnotes

Scott Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1.
5,000 of these shares were exercised and sold under the 10b5 Sales Plan.